{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:00Z","timestamp":1707524880404},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,26]]},"DOI":"10.7759\/cureus.34223","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T12:18:45Z","timestamp":1674735525000},"source":"Crossref","is-referenced-by-count":1,"title":["Cefepime-Induced Neurotoxicity Can Be Confused With Neuroleptic Malignant Syndrome, Catatonia and Serotonin Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Abu-Abaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhay","family":"Bahadli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamah","family":"Abdulhussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Abdulsahib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0028-3908(03)00188-6","article-title":"Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins","volume":"45","author":"Sugimoto M","year":"2003","unstructured":"Sugimoto M, Uchida I, Mashimo T, et al.. Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology. 2003, 45:304-14. 10.1016\/s0028-3908(03)00188-6","journal-title":"Neuropharmacology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.18700\/jnc.190109","article-title":"Cefepime-induced neurotoxicity","volume":"12","author":"Lee S-J","year":"2019","unstructured":"Lee S-J. Cefepime-induced neurotoxicity. J Neurocrit Care. 2019, 12:74-84. 10.18700\/jnc.190109","journal-title":"J Neurocrit Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks012","article-title":"Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports","volume":"67","author":"Durand-Maugard C","year":"2012","unstructured":"Durand-Maugard C, Lemaire-Hurtel AS, Gras-Champel V, et al.. Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports. J Antimicrob Chemother. 2012, 67:1297-9. 10.1093\/jac\/dks012","journal-title":"J Antimicrob Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.149","article-title":"Pharmacokinetics of cefepime in subjects with renal insufficiency","volume":"48","author":"Barbhaiya RH","year":"1990","unstructured":"Barbhaiya RH, Knupp CA, Forgue ST, Matzke GR, Guay DR, Pittman KA. Pharmacokinetics of cefepime in subjects with renal insufficiency. Clin Pharmacol Ther. 1990, 48:268-76. 10.1038\/clpt.1990.149","journal-title":"Clin Pharmacol Ther"},{"key":"ref5","article-title":"Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management","volume":"24","author":"Perry PJ","year":"2012","unstructured":"Perry PJ, Wilborn CA. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Ann Clin Psychiatry. 2012, 24:155-62.","journal-title":"Ann Clin Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.01.018","article-title":"Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database","volume":"398","author":"Lacroix C","year":"2019","unstructured":"Lacroix C, Kheloufi F, Montastruc F, Bennis Y, Pizzoglio V, Micallef J. Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database. J Neurol Sci. 2019, 398:196-201. 10.1016\/j.jns.2019.01.018","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne LE","year":"2017","unstructured":"Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL. Cefepime-induced neurotoxicity: a systematic review. Crit Care. 2017, 21:276. 10.1186\/s13054-017-1856-1","journal-title":"Crit Care"},{"key":"ref8","article-title":"Renal failure is a risk factor for cefepime-induced encephalopathy","volume":"21","author":"Garces EO","year":"2008","unstructured":"Garces EO, Andrade de Anzambuja MF, da Silva D, Bragatti JA, Jacoby T, Saldanha Thom\u00e9 F. Renal failure is a risk factor for cefepime-induced encephalopathy. J Nephrol. 2008, 21:526-34.","journal-title":"J Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considerations","volume":"72","author":"Grill MF","year":"2011","unstructured":"Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol. 2011, 72:381-93. 10.1111\/j.1365-2125.2011.03991.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx170","article-title":"Characterizing cefepime neurotoxicity: a systematic review","volume":"4","author":"Appa AA","year":"2017","unstructured":"Appa AA, Jain R, Rakita RM, Hakimian S, Pottinger PS. Characterizing cefepime neurotoxicity: a systematic review. Open Forum Infect Dis. 2017, 4:ofx170. 10.1093\/ofid\/ofx170","journal-title":"Open Forum Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-239744","article-title":"Negative myoclonus as the leading symptom in acute cefepime neurotoxicity","volume":"14","author":"Zimmermann P","year":"2021","unstructured":"Zimmermann P, Camenzind D, Beer JH, et al.. Negative myoclonus as the leading symptom in acute cefepime neurotoxicity. BMJ Case Rep. 2021, 14:e239744. 10.1136\/bcr-2020-239744","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21918","article-title":"Cefepime-induced neurotoxicity in a 74-year-old woman","volume":"14","author":"Sharma S","year":"2022","unstructured":"Sharma S, Khan M, Owais M, Haider A. Cefepime-induced neurotoxicity in a 74-year-old woman. Cureus. 2022, 14:e21918. 10.7759\/cureus.21918","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000809976.25111.df","article-title":"913: Inadvertent intrathecal cefepime administration: a neurologic emergency","volume":"50","author":"Rivera-Figueroa E","year":"2022","unstructured":"Rivera-Figueroa E, Mays W, Jones S, Henderson C. 913: Inadvertent intrathecal cefepime administration: a neurologic emergency. Critical Care Med. 2022, 50:453. 10.1097\/01.ccm.0000809976.25111.df","journal-title":"Critical Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7244\/cmj.2021.01.001","article-title":"Cefepime-induced cotard syndrome: a case report","author":"Howland M","year":"2021","unstructured":"Howland M, Markle C, Erickson JM, Soeprono T. Cefepime-induced cotard syndrome: a case report. Cam Med J. 2021, 10.7244\/cmj.2021.01.001","journal-title":"Cam Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001375","article-title":"Cefepime-induced catatonia, an unusual presentation [PREPRINT]","author":"Abrar Jeelani HM","year":"2021","unstructured":"Abrar Jeelani HM, Sheikh MM, Vemireddy L, Ram A, Alkhouri I. Cefepime-induced catatonia, an unusual presentation [PREPRINT]. Am J Ther. 2021, 10.1097\/MJT.0000000000001375","journal-title":"Am J Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-001-1170-9","article-title":"Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure","volume":"28","author":"Chatellier D","year":"2002","unstructured":"Chatellier D, Jourdain M, Mangalaboyi J, Ader F, Chopin C, Derambure P, Fourrier F. Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med. 2002, 28:214-7. 10.1007\/s00134-001-1170-9","journal-title":"Intensive Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/134243-cefepime-induced-neurotoxicity-can-be-confused-with-neuroleptic-malignant-syndrome-catatonia-and-serotonin-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:12Z","timestamp":1707508572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/134243-cefepime-induced-neurotoxicity-can-be-confused-with-neuroleptic-malignant-syndrome-catatonia-and-serotonin-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.34223","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,26]]}}}